Hemamylammal Sivakumar

784 total citations
15 papers, 575 citations indexed

About

Hemamylammal Sivakumar is a scholar working on Oncology, Biomedical Engineering and Surgery. According to data from OpenAlex, Hemamylammal Sivakumar has authored 15 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Biomedical Engineering and 3 papers in Surgery. Recurrent topics in Hemamylammal Sivakumar's work include Cancer Cells and Metastasis (8 papers), 3D Printing in Biomedical Research (7 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (3 papers). Hemamylammal Sivakumar is often cited by papers focused on Cancer Cells and Metastasis (8 papers), 3D Printing in Biomedical Research (7 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (3 papers). Hemamylammal Sivakumar collaborates with scholars based in United States. Hemamylammal Sivakumar's co-authors include Aleksander Skardal, Steven D. Forsythe, Konstantinos I. Votanopoulos, Julio Aleman, Andrea Mazzocchi, Edward A. Levine, Roy E. Strowd, Stephen B. Tatter, Adrian W. Laxton and Pierre L. Triozzi and has published in prestigious journals such as Advanced Drug Delivery Reviews, Scientific Reports and Biotechnology and Bioengineering.

In The Last Decade

Hemamylammal Sivakumar

14 papers receiving 571 citations

Peers

Countries citing papers authored by Hemamylammal Sivakumar

Since Specialization

Citations

This map shows the geographic impact of Hemamylammal Sivakumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hemamylammal Sivakumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hemamylammal Sivakumar more than expected).

Fields of papers citing papers by Hemamylammal Sivakumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hemamylammal Sivakumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hemamylammal Sivakumar. The network helps show where Hemamylammal Sivakumar may publish in the future.

Co-authorship network of co-authors of Hemamylammal Sivakumar

This figure shows the co-authorship network connecting the top 25 collaborators of Hemamylammal Sivakumar. A scholar is included among the top collaborators of Hemamylammal Sivakumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hemamylammal Sivakumar. Hemamylammal Sivakumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Bioengineered in vitro three-dimensional tumor models in endocrine cancers 2024 ·Endocrine Related Cancer ·Aleksander Skardal, Hemamylammal Sivakumar, (unknown), (unknown), Priya H. Dedhia	0
2	Three-dimensional bioprinting of in vitro tumor organoid and organ-on-a-chip models 2023 ·MRS Bulletin ·(unknown), (unknown), Hemamylammal Sivakumar, Aleksander Skardal	10
3	A 3D adrenocortical carcinoma tumor platform for preclinical modeling of drug response and matrix metalloproteinase activity 2023 ·Scientific Reports ·Priya H. Dedhia, Hemamylammal Sivakumar, (unknown), (unknown), (unknown), Xuguang Zheng, Katie Jones, (unknown), Jennifer L. Leight, Aleksander Skardal	8
4	Immersion bioprinting of hyaluronan and collagen bioink-supported 3D patient-derived brain tumor organoids 2022 ·Biomedical Materials ·(unknown), (unknown), Hemamylammal Sivakumar, (unknown), Adrian W. Laxton, Stephen B. Tatter, Roy E. Strowd, Aleksander Skardal	34
5	Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications 2022 ·Annals of Surgical Oncology ·Steven D. Forsythe, Hemamylammal Sivakumar, Richard A. Erali, Nadeem Wajih, Wencheng Li, Perry Shen, Edward A. Levine, Katherine E. Miller, Aleksander Skardal, Konstantinos I. Votanopoulos	34
6	Application of immune enhanced organoids in modeling personalized Merkel cell carcinoma research 2022 ·Scientific Reports ·Steven D. Forsythe, Richard A. Erali, (unknown), Hemamylammal Sivakumar, Wencheng Li, Aleksander Skardal, Shay Söker, Konstantinos I. Votanopoulos	12
7	αCT1 peptide sensitizes glioma cells to temozolomide in a glioblastoma organoid platform 2022 ·Biotechnology and Bioengineering ·(unknown), (unknown), Hemamylammal Sivakumar, Louisa Mezache, (unknown), Monica Venere, Katelyn E. Swindle‐Reilly, Rengasayee Veeraraghavan, Aleksander Skardal	10
8	Strategies for developing complex multi-component in vitro tumor models: Highlights in glioblastoma 2021 ·Advanced Drug Delivery Reviews ·(unknown), Hemamylammal Sivakumar, Aleksander Skardal	14
9	Immersion Bioprinting of Tumor Organoids in Multi-Well Plates for Increasing Chemotherapy Screening Throughput 2020 ·Micromachines ·Erin K. Maloney, (unknown), Hemamylammal Sivakumar, (unknown), Julio Aleman, Shiny Amala Priya Rajan, Steven D. Forsythe, Andrea Mazzocchi, Adrian W. Laxton, Stephen B. Tatter, Roy E. Strowd, Konstantinos I. Votanopoulos, Aleksander Skardal	138
10	Personalized Identification of Optimal HIPEC Perfusion Protocol in Patient-Derived Tumor Organoid Platform 2020 ·Annals of Surgical Oncology ·Steven D. Forsythe, Shyama Sasikumar, Omeed Moaven, Hemamylammal Sivakumar, Perry Shen, Edward A. Levine, Shay Söker, Aleksander Skardal, Konstantinos I. Votanopoulos	42
11	Multi-Cell Type Glioblastoma Tumor Spheroids for Evaluating Sub-Population-Specific Drug Response 2020 ·Frontiers in Bioengineering and Biotechnology ·Hemamylammal Sivakumar, Mahesh Devarasetty, David E. Kram, Roy E. Strowd, Aleksander Skardal	28
12	Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study 2019 ·Annals of Surgical Oncology ·Konstantinos I. Votanopoulos, Steven D. Forsythe, Hemamylammal Sivakumar, Andrea Mazzocchi, Julio Aleman, Lance D. Miller, Edward A. Levine, Pierre L. Triozzi, Aleksander Skardal	127
13	Development of a Colorectal Cancer 3D Micro-tumor Construct Platform From Cell Lines and Patient Tumor Biospecimens for Standard-of-Care and Experimental Drug Screening 2019 ·Annals of Biomedical Engineering ·Steven D. Forsythe, (unknown), Mahesh Devarasetty, Hemamylammal Sivakumar, William H. Gmeiner, Shay Söker, Konstantinos I. Votanopoulos, Aleksander Skardal	35
14	Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study 2018 ·Annals of Surgical Oncology ·Konstantinos I. Votanopoulos, Andrea Mazzocchi, Hemamylammal Sivakumar, Steven D. Forsythe, Julio Aleman, Edward A. Levine, Aleksander Skardal	67
15	Exploration of Dynamic Elastic Modulus Changes on Glioblastoma Cell Populations with Aberrant EGFR Expression as a Potential Therapeutic Intervention Using a Tunable Hyaluronic Acid Hydrogel Platform 2017 ·Gels ·Hemamylammal Sivakumar, Roy E. Strowd, Aleksander Skardal	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact